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utiles au patient et au médecin pour le suivi des traitements. Ce carnet a été
élaboré selon les recommandations « d’élaboration de document d’information
destiné au patient » de la Haute Autorité de Santé. Les recommandations des
sociétés savantes concernant la prise en charge de la spasticité, les bases de
données d’information sur les médicaments anti-spastiques ont également été
consultées.
Résultat.– Le format retenu est identique à celui du carnet de suivi des anti-
vitamine K. Il contient des informations pratiques, pour le patient, sur la
spasticité et la toxine botulinique et des données médicales concernant les
séances d’injection (date, dose injectée, muscle concerné). Le carnet sera
présenté par le médecin puis remis au patient au préalable de la première
injection, il sera ensuite apporté par le patient à chaque séance d’injection et
complété par le médecin.
Discussion.– Le travail est original, il n’existe actuellement pas de support
d’information de ce type. Cet outil devrait permettre d’améliorer la qualité de la
prise en charge des patients et de répondre à une de leurs demandes : disposer en
plus de l’information orale d’un support écrit à conserver.
Conclusion.– La validation du projet par la Société Française de Médecine
Physique et Réadaptation est la prochaine étape ainsi que l’évaluation du carnet
auprès des patients. Il sera envisagé ensuite une mise à disposition du carnet à
l’ensemble des médecins impliqués dans l’utilisation de la toxine botulinique.
http://dx.doi.org/10.1016/j.rehab.2013.07.311
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Therapeutic education
Neurological rehabilitation departments support patients with severe stroke. In
addition to physical rehabilitation, pharmacological treatment and dietary
measures are implemented to prevent stroke recurrence. As part of an
educational process around patient adherence to treatment, we have developed
therapeutic brochures of drugs prescribed after a stroke.
The information brochures were developed by two pharmacists AJD and AR
based on the recommendations of the HAS ‘‘development of patient
information document’’. They targeted drugs for cardiovascular prevention
(antihypertensive, antiplatelet, AVK and new oral anticoagulants, statins) and
medications used in the treatment of neuropathic pain, spasticity, and urinary
disorders. The therapeutic supports were validated by rehabilitation physicians
and neurologists. An evaluation was then conducted by interview (from a
questionnaire) of patients/caregivers during hospital stay. The objective was to
test the brochures on the substance and form. Changes have been made
following the assessment.
Nineteen brochures were made, 15 for ‘‘drugs’’ and four for the ‘‘therapeutic
care’’ of secondary prevention, urinary disorders, spasticity, neuropathic pain. The
information brochures were tested by nine patients and three caregivers. They
have been found useful to very useful, and providing new relevant information.
Taking into account the comments of patients has led us to ‘‘simplify’’ certain
words or phrases and reformulate key messages. Finally, the evaluation has shown
that for an optimal understanding, the information brochure had to be explained by
physician or pharmacist before to be given to patient.
This work is original, there is currently no specific therapeutic tools about
medication after stroke. It is part of the educational interventions advocated by
the national stroke from 2010 to 2014. The brochures were submitted to
SOFMER and SFNV (Société Française Neurovasculaire) for validation. They
could be used in clinical departments neurological and rehabilitation to support
the explanation of the order at hospital discharge. In addition, they could be
made available to community pharmacists and general physicians, as a tool to
support long-term care patient.
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Introduction.– Rheumatoid arthritis is the most common chronic inflammatory
rheumatism. One of first causes of disability, not always severe, may be
fluctuating and inconspicuous nevertheless binding and painful sounding on
daily life.
Aim.– Determine the place of therapeutic education in the treatment of arthritis.
Material and method.– Prospective study on 60 patients with rheumatoid taken
in charge by MPR from 01/01/2011 to 31/03/2013 who have completed a
program of therapeutic education.
Results.– Our 60 patients, 52 are women. The average age is 47.18 years. About
36,66% have professional, 65% activity are married with children.
History personal, we find an HTA (11.67%), a diabete’s induced (18.33%),
dyslipidemia (1.67%) and a rheumatoid arthritis family (11.67%).
For seniority, arthritis is changing less than five years (26.67%) and more than
10 years (31.67%) with notion of juvenile chronic arthritis (6.67%). Evolution
by boost remission (100%).
For medical treatment, 44% are under methotrexate, 75% under corticosteroids
(including 8.33% less than 02 years) with a progressive (21,27%) withdrawal;
86.67% benefited from biotherapy. About 78,33% take NSAIDs.
Joint stiffness are noted (18.33%) predominant in the knees (80% have joint
deformations with 40 per cent in the hands and wrists). Associated dry
syndrome (13.33%). About 30.97% have x-rays of the hands, feet and knees
highlighting especially by the carpites and tarsites.
Sixty patients were included in the therapeutic learning program but 11 have not
gone down for family reasons. The median of the satisfaction scale is 09,06/10.
Three months after the therapeutic learning program, it should be noted a
decrease in VAS pain (63.26%), DAS28VS (69.38%) decreased, (63.26%) HAD
decreased and a decrease in HAQ (61.82%) with the quasi-quotidian port of the
palm rest orthotics (40%).
Discussion / Conclusion.– It appears clear that the reduction of the pain,
functional and psychological improvement are proportional, with an improve-
ment in the quality of life in more than 60% of our patients after the therapeutic
learning program. However, no study to date has proven its effectiveness on the
activity of the disease.
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Objective.– A study was led by Roussel and Deccache to understand better the
link between the representations and the practices of professionals of care doing
therapeutic patient education. The objective of our study was to know the
representations of nursing formed in the therapeutic patient education
participating in a same program at the HOSPITAL of Montpellier.
Method.– A questionnaire with open questions was handed to 8 participating in
a therapeutic educational program concerning patients affected by spondylitis,
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